First description of an extended-spectrum-beta-lactamase-producing multidrug-resistant Escherichia fergusonii strain in a patient with cystitis.
Extended-spectrum-beta-lactamase (ESBL)-producing organisms have captured the attention of clinicians and laboratorians and are agents of nosocomial and community onset infections (J. D. Pitout and K. B. Laupland, Lancet Infect. Dis. 8:159-166, 2008). ESBLs in many enterobacteriaceae and in nonfermenting Gram-negative organisms have been described (K. Bush and G. A. Jacoby, Antimicrob. Agents Chemother. 54:969-976, 2010). We present the first case of a clinical isolate of multidrug-resistant Escherichia fergusonii expressing an extended-spectrum-beta-lactamase (ESBL).
Lagacé-Wiens
Philippe R S
PR
Department of Medical Microbiology and Infectious Diseases, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. plagacewiens@sbgh.mb.ca
Baudry
Patricia J
PJ
Pang
Paulette
P
Hammond
Gregory
G
D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003556:Cystitis / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D004756:Enterobacteriaceae Infections / Q000175:diagnosis* / Q000382:microbiology; D004925:Escherichia / Q000145:classification* / Q000187:drug effects / Q000201:enzymology* / Q000302:isolation & purification; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D001618:beta-Lactamases / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D001618:beta-Lactamases
J Clin Microbiol. 1985 Jan;21(1):77-81
3968204
J Clin Microbiol. 2008 Apr;46(4):1551-2
18256229
Antimicrob Agents Chemother. 2004 Apr;48(4):1204-14
15047521
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
19995920
J Infect. 2008 Dec;57(6):441-8
18990451
Infez Med. 2009 Dec;17(4):259-60
20046110
Vet Rec. 1999 May 1;144(18):511
10358892
J Antimicrob Chemother. 2006 Jun;57(6):1262-3
16565157
Lancet Infect Dis. 2008 Mar;8(3):159-66
18291338
J Diarrhoeal Dis Res. 1999 Jun;17(2):85-7
10897892